Disappointing trial results of quit-smoking vaccine staggers Biotech
Earlier this Monday Rockville biotech company, Nabi Bioharmaceuticals, declared that a phase 3 clinical trial failed to meet its primary
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine